Tagged with

Lilly As a top 10 global MNC, how does Lilly’s Indonesian affiliate compare with the group’s global positioning? Lilly Indonesia’s position is a bit behind our desired global positioning, but it is appropriate when you consider that Lilly has only started to invest in Indonesia recently. What we see is a…

Le Meridien Jakarta As the general manager of Le Meridien Jakarta, what is your point of view on the evolution of Jakarta’s infrastructure? Do you believe that hosting the APEC 2013 will put Indonesia more in the spotlight? Definitely. I believe that Jakarta and Indonesia– not only just because of the APEC –…

Austria   Historically, Austria was the dominant political power in Central Europe under the Habsburg dynasty which ruled until World War I. Although the 20th century has been marked by significant shake ups and power shifts between countries in Europe, Austria remains today a key strategic market thanks to its steady economic…

As Novo Nordisk is celebrating its 90 year anniversary this year, may you please begin this interview by discussing how the company, since its beginning, has changed the face of diabetes?  Historically, there have been two companies that have changed the face of diabetes in the world— Eli Lilly that…

Juan Diego Sr. Gutierrez, when we interviewed your father in 2010, he described to us the strong potential of the medical industry in Colombia in the future. Since that time, would you say that Siplas has been able to take advantage of that potential? And if so, how? Siplas has been growing…

Novo Nordisk CEO Lars Rebien Sørensen discusses the company’s commitment to curing diabetes, his own history with the organisation, and the values that have served Novo Nordisk so well in their global operations. As Novo Nordisk is celebrating its 90 year anniversary this year, please begin by discussing how the company…

What is your background, and how did you become involved with Grupo Amarey? My first job in the medical industry was with Johnson & Johnson Medical, which back then was a small company in Colombia.. Due to its small size and newness, this job was an excellent experience with lots…

What is Pfizer’s current position in the Danish market?  We are first or second in the market, depending on how you count. There are two unique factors about the Danish Pharmaceutical Market: a high share of generics and parallel imports. When you look at companies’ reported statements they do not…

Novartis In our last meeting, you said that you were looking forward to a decade of continuous growth and to be the number one partner of choice for patients, physicians, governments and institutions. In what way have you been able to do that? Novartis Colombia has a broader portfolio compared to…

Cedegim Colombia               The operations and sales managers of Cegedim Colombia discuss the impact of healthcare reform on the Colombian pharma market, partnering opportunities in the country, and the outlook for CRM in 2013 and beyond. Can you briefly summarize Cegedim Colombia’s scope of activities and…

A Regulatory Overview of the Mexican Healthcare market by ALEJANDRO LUNA FANDIÑO, Partner  Olivares & Cia. Olivares & Cia T +52 55 5322 3080 F +52 55 5322 3001 E mailto:alf@olivares.com.mx W www.olivares.com.mx I. Pricing & Reimbursement.  Price control in the private sector is based on a scheme of self-…

You have an extensive background in the healthcare sector, with positions in Colciencias, the Department of Public Health, and the National University of Colombia. What can you bring from these experiences to the role of Director General of INS? The INS is the head of the national surveillance system. It…